Company Overview of MetronomX, Pte. Ltd.
MetronomX, Pte. Ltd. develops cancer chemotherapeutic metronomic therapies. It develops MNX-100 for relapsing and/or refractory neuroblastoma and medulloblastoma; and MNX-200, a metronomic formulation of an approved and used IV cancer chemotherapeutic drug. The company was founded in 2010 and is based in Houston, Texas.
5138 Cheena Drive
Houston, TX 77096
Founded in 2010
Key Executives for MetronomX, Pte. Ltd.
Similar Private Companies By Industry
|Abbott Laboratories Residential Development Fund, Inc.||United States|
|Blue Ash Therapeutics, LLC||United States|
|Zuellig Botanicals, Inc.||United States|
|Asahi Kasei Pharma America Corporation||United States|
|Raritan Pharmaceuticals Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact MetronomX, Pte. Ltd., please visit www.metronomxgroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.